Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 15,843 | 3,061 | 6,501 | 5,684 | 8,610 |
| Operating Income | -15,843 | -3,061 | -6,501 | -5,684 | -8,610 |
| Interest Expense | 0 | 0 | 0 | 0 | 230 |
| Other Income | 979 | 2,771 | 602 | -2,311 | 128 |
| Pre-tax Income | -14,864 | -290 | -5,899 | -7,995 | -8,712 |
| Income Tax | -1,541 | N/A | 163 | N/A | 73 |
| Net Income Continuous | -13,323 | -290 | -6,062 | -7,995 | -8,785 |
| Net Income | $-13,323 | $-290 | $-6,062 | $-7,995 | $-8,785 |
| EPS Basic Total Ops | 15.53 | -26.75 | -63.00 | -83.50 | -2.00 |
| EPS Basic Continuous Ops | 7.16 | -0.82 | -44.79 | -67.16 | 12.51 |
| EPS Diluted Total Ops | 15.53 | -26.75 | -63.00 | -83.50 | -2.00 |
| EPS Diluted Continuous Ops | 7.16 | -0.82 | -44.79 | -67.16 | 12.51 |
| EBITDA(a) | $-15,843 | $-3,061 | $-6,501 | $-5,684 | $-8,609 |